Morningstar
•
May 08, 2026
Becton, Dickinson and Company: BD Begins Its Post-Life Sciences Era
Summary
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Intervent
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Stryker Corp
May 12, 2026
•
SYK
Market Digest: NOV, SYK, PPC, ABNB, RDDT
May 12, 2026
•
PPC, RDDT, SYK, NOV, ABNB
Analyst Report: Medtronic plc
May 11, 2026
•
MDT
Analyst Report: Boston Scientific Corporation
May 08, 2026
•
BSX
Analyst Profile
Alex Morozov
Regional Director
Alex Morozov, CFA, is director of European equity research for Morningstar Holland BV, a wholly owned subsidiary of Morningstar, Inc. He leads a team of equity analysts based in Europe who cover European and global companies across all major sectors of the economy.Before assuming his current role in 2014, Morozov was head of global healthcare equity research. Previously, he was a senior equity analyst, covering the medical instruments, life sciences, and diagnostics industries. Before joining Morningstar in 2006, Morozov worked in the insurance industry.Morozov holds a bachelor’s degree in finance, with a minor in mathematics, from the University of Missouri. He also holds the Chartered Financial Analyst® designation.
